QIM
KYNB

Quantitative Investment Management’s Kyntra Bio KYNB Stock Holding History

Quantitative Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,404
Closed -$2.2M – 714
2018
Q2 		$2.2M Sell
1,404
-256
-15% -$334K 0.05% 342
2018
Q1 		$1.92M Sell
1,660
-300
-15% -$395K 0.03% 463
2017
Q4 		$2.32M Buy
+1,960
New +$2.46M 0.03% 474

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Quantitative Investment Management's KYNB Position: Q3 2018 in Review

Quantitative Investment Management sold out of Kyntra Bio (KYNB) in Q3 2018, closing a stake of 1,404 shares — an estimated $2.2M sold.

Quantitative Investment Management first reported a position in KYNB in Q4 2017 and held it in 3 quarters. The position peaked at $2.32M in Q4 2017. 187 funds tracked by Wall St. Rank hold KYNB as of Q3 2018.

  • Quantitative Investment Management reported no remaining Kyntra Bio position as of Q3 2018 after selling out during the quarter.
  • Quantitative Investment Management sold 1,404 Kyntra Bio shares in Q3 2018, an estimated $2.2M.
  • Quantitative Investment Management first reported a position in Kyntra Bio in Q4 2017 and held it in 3 quarters.
  • Quantitative Investment Management's Kyntra Bio position peaked at $2.32M in Q4 2017.
  • 187 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2018.

Based on Quantitative Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.